SINGULAIR
Google image searchProduct monograph
Active ingredient
montelukast (montelukast sodium), 4 MG/SACHET
DIN: 02247997
Dosage form(s): GRANULES
Route(s) of administration: ORAL
Schedule: Prescription
Company: ORGANON CANADA INC.
Date: 10-JAN-2023
ATC:
- R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
- R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
- R03DC — Leukotriene receptor antagonists (ATC, ATC/DDD)
- R03DC03 — MONTELUKAST (ATC/DDD)
Reference brand drug: Singulair
